# The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.

> **NCT01228240** · PHASE4 · COMPLETED · sponsor: **Zanjan University of Medical Sciences** · enrollment: 18 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2 AND Metformin

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01228240
- **Lead sponsor:** Zanjan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-07
- **Final completion:** 2009-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228240, "The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01228240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*